Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ENSACOVE safely and effectively. See full prescribing information for ENSACOVE. ENSACOVETM (ensartinib) capsules, for oral use Initial U.S. Approval: 2024
Medication labelWhy this: Advisory · dailymed-prescription
ENSACOVE is indicated for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive locally advanced or metastatic non-small cell lung cancer (NSCLC)as detected by an FDA-approved test [see Dosage and Administration (2.1)] who have not previously received an ALK-inhibitor.
- generic_name
- ensartinib
- product_names
- ensartinib
- ndc
- 83076-1025, 83076-1025-3, 83076-1100, 83076-1100-6
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en